BRPI0513051A - combinação de inibidores de transcriptase reversa e de protease anti-hiv - Google Patents

combinação de inibidores de transcriptase reversa e de protease anti-hiv

Info

Publication number
BRPI0513051A
BRPI0513051A BRPI0513051-4A BRPI0513051A BRPI0513051A BR PI0513051 A BRPI0513051 A BR PI0513051A BR PI0513051 A BRPI0513051 A BR PI0513051A BR PI0513051 A BRPI0513051 A BR PI0513051A
Authority
BR
Brazil
Prior art keywords
combination
reverse transcriptase
hiv protease
transcriptase inhibitors
hiv
Prior art date
Application number
BRPI0513051-4A
Other languages
English (en)
Inventor
Richard Marinus Wil Hoetelmans
Original Assignee
Tibotec Pharm Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tibotec Pharm Ltd filed Critical Tibotec Pharm Ltd
Publication of BRPI0513051A publication Critical patent/BRPI0513051A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

COMBINAçãO DE INIBIDORES DE TRANSCRIPTASE REVERSA E DE PROTEASE ANTI-HIV. A presente invenção refere-se a uma combinação que compreende (i) tenofovir ou seu derivado fumarato de disoproxila; (ii) ritonavir; e (iii) TMC114, útil para o tratamento de infecções por HIV. A mesma refere-se ainda a formulações farmacêuticas que contêm tais combinações.
BRPI0513051-4A 2004-07-08 2005-07-08 combinação de inibidores de transcriptase reversa e de protease anti-hiv BRPI0513051A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04103256 2004-07-08
PCT/EP2005/053266 WO2006005720A1 (en) 2004-07-08 2005-07-08 Combination of anti-hiv reverse transcriptase and protease inhibitors

Publications (1)

Publication Number Publication Date
BRPI0513051A true BRPI0513051A (pt) 2008-04-22

Family

ID=34929311

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0513051-4A BRPI0513051A (pt) 2004-07-08 2005-07-08 combinação de inibidores de transcriptase reversa e de protease anti-hiv

Country Status (19)

Country Link
US (1) US20070208009A1 (pt)
EP (1) EP1765337B1 (pt)
JP (1) JP2008505870A (pt)
CN (1) CN1984654A (pt)
AT (1) ATE406161T1 (pt)
AU (1) AU2005261701A1 (pt)
BR (1) BRPI0513051A (pt)
CA (1) CA2572551A1 (pt)
DE (1) DE602005009366D1 (pt)
DK (1) DK1765337T3 (pt)
ES (1) ES2313394T3 (pt)
HR (1) HRP20080612T3 (pt)
MX (1) MXPA06014930A (pt)
NZ (1) NZ551841A (pt)
PL (1) PL1765337T3 (pt)
RU (1) RU2368380C2 (pt)
SI (1) SI1765337T1 (pt)
WO (1) WO2006005720A1 (pt)
ZA (1) ZA200700176B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060135562A1 (en) * 2004-11-16 2006-06-22 Boehringer Ingelheim International Gmbh Method for treating HIV infection through co-administration of tipranavir and darunavir
EP2214668A1 (en) * 2007-10-29 2010-08-11 Cipla Limited Novel antiretroviral combination
GT200800303A (es) * 2007-12-24 2009-09-18 Combinacion anti-retroviral
CN102876714A (zh) * 2011-09-07 2013-01-16 深圳市易瑞生物技术有限公司 用慢病毒检测hiv耐药表型
WO2013057469A1 (en) * 2011-10-20 2013-04-25 Cipla Limited Pharmaceutical antiretroviral compositions
CN104884063A (zh) * 2012-10-23 2015-09-02 西普拉有限公司 抗逆转录病毒药物组合物
IN2013MU01749A (pt) * 2013-05-15 2015-06-26 Cipla Ltd
CA2918707A1 (en) * 2013-08-29 2015-03-05 Teva Pharmaceuticals Industries Ltd. Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir and a monolithic tablet comprising darunavir and ritonavir
CA2942877A1 (en) * 2014-04-08 2015-10-15 Nitzan SHAHAR Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
GB201509431D0 (en) * 2015-06-01 2015-07-15 Equigerminal Sa Antiviral composition
US10213507B2 (en) * 2017-03-10 2019-02-26 The Florida International University Board Of Trustees Compositions and methods for treating HIV-associated neurocognitive disorders
RU2662160C9 (ru) * 2017-07-03 2018-10-22 Александрович Иващенко Андрей Комбинированный лекарственный препарат для терапии вирусных инфекций

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI286476B (en) * 2001-12-12 2007-09-11 Tibotec Pharm Ltd Combination of cytochrome P450 dependent protease inhibitors

Also Published As

Publication number Publication date
CN1984654A (zh) 2007-06-20
SI1765337T1 (sl) 2009-02-28
MXPA06014930A (es) 2007-02-28
NZ551841A (en) 2009-04-30
CA2572551A1 (en) 2006-01-19
EP1765337B1 (en) 2008-08-27
JP2008505870A (ja) 2008-02-28
RU2007104774A (ru) 2008-08-20
HRP20080612T3 (en) 2009-01-31
US20070208009A1 (en) 2007-09-06
AU2005261701A1 (en) 2006-01-19
ZA200700176B (en) 2008-04-30
ES2313394T3 (es) 2009-03-01
ATE406161T1 (de) 2008-09-15
WO2006005720A1 (en) 2006-01-19
EP1765337A1 (en) 2007-03-28
DK1765337T3 (da) 2009-01-05
RU2368380C2 (ru) 2009-09-27
DE602005009366D1 (de) 2008-10-09
PL1765337T3 (pl) 2009-02-27

Similar Documents

Publication Publication Date Title
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
MY142948A (en) Benzophenones as inhibitors of reverse transcriptase
TR200103575T2 (tr) Sülfonamid ve sülfamid ikameli/katkılı imidazokinolinler
CY1111613T1 (el) Μεθοδοι για την αντιμετωπιση της μολυνσης απο hiv
NO20071077L (no) Fosfonatanaloger til HIV-inhibitorforbindelser
CY1107419T1 (el) Προφαρμακα αντι-ιικων μεσων απο πιπεραζινη και υποκατεστημενη πιπεριδινη
CL2004000192A1 (es) Uso de compuestos derivados de 2-aminopirimidina para preparar un medicamento para la prevencion de una infeccion por vih relaciones sexuales o un contacto intimo en la pareja.
SE0102315D0 (sv) Compounds
ATE274330T1 (de) Gleitschutz fur einen gehäusekopf medizinischer instrumente
EA200700488A1 (ru) S-ТРИАЗОЛИЛ-α-МЕРКАПТОАЦЕТАНИЛИДЫ КАК ИНГИБИТОРЫ ОБРАТНОЙ ТРАНСКРИПТАЗЫ ВИЧ
RS20110578A2 (en) MACROCYCLIC CARBOXYLIC ACIDS AND ACYLSULPHONAMIDES AS HCV REPLICATION INHIBITORS
DK1465626T3 (da) Farmaceutiske præparater (kit) der omfatter dihydropyridinonforbindelser og et immunregulatorisk (eller et antiinflammatorisk) middel samt anvendelser deraf
NO20070866L (no) Antivirale forbindelser.
DE60323133D1 (de) Cyclohexylverbindungen als ccr5-antagonisten
DK1556021T3 (da) Farmaceutiske sammensætninger omfattende flavonoider og menthol samt fremgangsmåder til behandling med brug af nævnte sammensætninger
DE60322423D1 (de) Pyrrolidin- und azetidinverbindungen alsccr5-antagonisten
NO974147D0 (no) Heterocykelkarbonyl aminosyre hydroksyetylamino sulfonamid retroviral protease
DE60324014D1 (de) Heterocyclische verbindungen alsccr5-antagonisten
ATE414526T1 (de) Zubereitungen zur behandlung von arthritischen erscheinungen
DK1694660T3 (da) Fremgangsmåde til fremstilling af vandfri og hydrerede aktive farmaceutiske bestanddele (API's); stabile farmaceutiske sammensætninger fremstillet af disse og anvendelser af disse sammensætninger
ATE521624T1 (de) Peptide und medizinische zusammensetzungen mit denselben
HK1107699A1 (en) Ritonavir analogous compound useful as retroviral protease inhibitor, preparation of the ritonavir analogous compound and pharmaceutical composition for the ritonavir analogous compound
MA27922A1 (fr) Formulations semi-solides de derives d'azetidine
HUP0401633A2 (hu) Irbesartan alkalmazása pulmonális magas vérnyomás megelőzésére vagy kezelésére alkalmas gyógyszerkészítmény előállítására
DE602004005821D1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012.